Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Fuji
Citi
Teva
McKinsey
UBS

Generated: July 23, 2019

DrugPatentWatch Database Preview

Patent: 7,514,415

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,514,415
Title:Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides
Abstract: The present disclosure relates to oligodeoxynucleotides that suppress an immune response. Methods are disclosed for preventing or treating inflammatory arthropathies by administering a therapeutically effective amount of a suppressive oligodeoxynucleotide.
Inventor(s): Klinman; Dennis (Potomac, MD), Zeuner; Rainald (Kiel, DE), Verthelyi; Daniela (Potomac, MD), Gursel; Ihsan (Rockville, MD), Gursel; Mayda (Rockville, MD)
Assignee: The United States of America as represented by the Department of Health and Human Services (Washington, DC) N/A (N/A)
Application Number:10/523,273
Patent Claims:see list of patent claims

Details for Patent 7,514,415

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Biovitrum Ab KINERET anakinra VIAL; SUBCUTANEOUS 103950 003 2001-11-14 ➤ Sign Up The United States of America as represented by the Department of Health and Human Services (Washington, DC) N/A ( ➤ Sign Up RX search
Biovitrum Ab KINERET anakinra VIAL; SUBCUTANEOUS 103950 002 2001-11-14 ➤ Sign Up The United States of America as represented by the Department of Health and Human Services (Washington, DC) N/A ( ➤ Sign Up RX search
Biovitrum Ab KINERET anakinra VIAL; SUBCUTANEOUS 103950 001 2001-11-14 ➤ Sign Up The United States of America as represented by the Department of Health and Human Services (Washington, DC) N/A ( ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Cipla
Covington
US Department of Justice
Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.